Sunday, October 13, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

RSV Vaccine Approved by FDA for Adults 60 and Older

RSV Vaccine Approved by FDA for Adults 60 and Older

The U.S. Food and Drug Administration (FDA) has approved a license for the world’s first respiratory syncytial virus (RSV) vaccine to be given to people 60 years of age and older. Pharmaceutical and biotechnology company GSK (formerly GlaxoSmithKline) has already begun manufacturing doses of the vaccine, which will be sold as early as this fall […]

Global Pediatric Vaccines Market to Exceed $69 Billion by 2030

Global Pediatric Vaccines Market to Exceed  Billion by 2030

A report released by Coherent Market Insights showed that pediatric vaccines market will surpass $69.482 billion by 2030.1 The main pharmaceutical companies in the global market for pediatric vaccines include Bharat Biotech, Emergent BioSolutions, GSK, Indian Immunologicals, Merck, Panacea Biotec, Pfizer, Sanofi, Serum Institute and Zydus Cadila.2 Pediatric Vaccine Approvals by Governments Will Drive Vaccine […]

Pharma Developing Bird Flu Vaccine for Humans As Animals Get Sick

Pharma Developing Bird Flu Vaccine for Humans As Animals Get Sick

Pharmaceutical companies GSK (formerly known as GlaxoSmithKline), Moderna and CSL Seqirus announced that they are developing and ready to test human vaccines against avian influenza H5N1 (also known as bird flu) as a precautionary measure to prepare for what they believe may be a future pandemic.1 Now that certain strains of H5N1 have infected not […]

Guillain-Barré Syndrome Linked to the RSV Vaccine

Guillain-Barré Syndrome Linked to the RSV Vaccine

The potential risk of Guillain-Barré syndrome (GBS) developing after receipt of Pfizer’s respiratory experimental syncytial virus (RSV) vaccine have prompted the U.S. Food and Drug Administration (FDA) to request that Pfizer conduct a post-marketing safety study if the vaccine is approved for use in the United States this spring.1 The RSV vaccine manufactured by GlaxoSmithKline […]

Another Shot at a Vaccine for Lyme Disease

Another Shot at a Vaccine for Lyme Disease

The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]

Search in Site

To search in site, type your keyword and hit enter

Search